The Peierls Foundation
investment firm
About
The Peierls Foundation is a HSF's institutional contributors.
- New York,New York,United States
Highlights
Details
- Founded date
- Jan 1, 1988
- Operating Status
- Active
- Investor Type
- Government Office
Investments
Number of Investments
Number of Lead Investments
8
0
The Peierls Foundation has made 8 investments. Their most recent investment was on
May 15, 2019, when ArcherDX raised $60M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
May 15, 2019
ArcherDX
|
Series B | $60M | Biopharma | — |
|
Mar 20, 2018
ArcherDX
|
Series A | $35M | Biopharma | — |
|
Oct 18, 2010
BiOptix Diagnostics
|
Series B | $9M | Life Science | — |
|
Jun 3, 2009
Viridian Therapeutics
|
Series A | $4M | Biotechnology | — |
|
Sep 17, 2008
Quantia
|
Series Unknown | $5.05M | Communities | — |
Exits
The Peierls Foundation has had 3 exits. The Peierls Foundation most notable exits include ArcherDX , Viridian Therapeutics
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Dec 20, 2022 | ArcherDX | M&A | Biopharma | Detail |
| Apr 24, 2017 | Viridian Therapeutics | IPO | Biotechnology | Detail |
| Jan 1, 2009 | ARCA biopharma | IPO | Biotechnology | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
